| 2025 State Policy Plan |
2025 - 2026 State Policy PlanAccelerating Delaware's Life Science LeadershipDelaware’s thriving life science ecosystem includes pharmaceutical and biotechnology firms, instrumentation, medical device and diagnostic companies, research, development and manufacturing firms, agricultural biotech, hospital and academic research institutes, and an array of essential business service providers. The sector’s significant recent growth has been fueled by new company formation, strategic investments in key sites and facilities, and the expansion of major global employers. Today, the sector directly supports more than 12,000 jobs across research and development, manufacturing, medical devices, biotechnology, and pharmaceutical production, with thousands more high-value jobs in construction, industrial services, law, accounting, consulting and other fields critical to the industry’s success. Key Priorities:CapitalR&D activities that advance and facilitate the commercialization of life science innovations are essential to the sector’s long-term growth and the state should be creative and targeted with programs and incentives that boost this activity while providing optimum taxpayer ROI. These efforts play a critical role in fostering groundbreaking research, attracting top-tier talent to our research universities and institutes and companies of all sizes, encouraging the establishment and growth of innovative companies and positioning Delaware as a leader in this high-value industry. Learn More TalentDelaware’s unique combination of collaboration and adaptability can position it as a national leader in fostering productive workforce partnerships between industry, government, and educational institutions. This ecosystem is essential for developing a world class STEM talent pipeline to meet the evolving demands of the life sciences sector. Learn More InfrastructureDelaware’s intimate science and technology community provides a unique opportunity to drive economic growth by aligning and leveraging key capabilities in science, business and cutting-edge areas like cell and gene therapy, biomanufacturing and AI. The state’s economic development framework should facilitate that alignment while offering a cohesive and efficient system for businesses to access resources, navigate state programs and foster innovation. To remain competitive, the state’s economic development infrastructure should reflect the speed and agility required by dynamic industries like life sciences, manufacturing and technology. Further, Delaware’s economic strategy and advocacy efforts would benefit from a clear points of contact and accountability within the executive administration. Learn More AccessDelaware life science researchers and workers devote their lives to bringing innovative medicines and other technologies to patients. We must expand access to these life-saving treatments and diagnostics and reduce unnecessary costs by: lowering costs for patients, increasing access, ensuring transparency, investing in health IT and telemedicine, promoting biotech solutions for preventative care, and including industry in public health initiatives. Learn More
Download Report
Contact Us
"Unique among industries, the research, development and successful manufacturing of life science products and technologies requires immense time, study and investment over many years,” said Fleming. “To ensure our continued growth – and enhance Delaware’s posture in a competitive regional and indeed international market – it is essential the state advance a strategy focused on common-sense proposals that drive continued life science innovation and investment and support the dedicated Delaware scientists who devote their lives to bringing biomedical innovation to patients in need.” ![]() Michael Fleming Stay Up To Date
Sign up to receive our newsletter, upcoming event notifications, and industry news
Sign Up Now
Our Sponsors |
10/27/2025Team led by NIIMBL is Selected for Gates Grand Challenge $10.5 Million Funding Award
10/23/2025Viewpoint: Innovation and access is the life science industry’s central mission
10/23/2025Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
10/20/2025LabWare expands global lab software solutions from Delaware headquarters
12/10/2025
2025 December BioBriefing
1/22/2026
January 2026 BioBreakfast